About Index Trending news
Analyze
Pricing
CytomX Therapeutics

CytomX Therapeutics

CytomX Therapeutics

CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.
I work here Suggest edits
More info

Elsewhere

Companies in the same industry

Swallow Solutions Swallow Solutions StrideBio, LLC StrideBio, LLC Cybrexa Therapeutics Cybrexa Therapeutics Acessa Acessa Diasome Diasome Actinobac Biomed, Inc. Actinobac Biomed, Inc. Fedora Pharmaceuticals Fedora Pharmaceuticals Neurohacker Neurohacker Meissa Vaccines Meissa Vaccines GEN1 Biotechnology GEN1 Biotechnology

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3
Add info
Latest funding Show all
Venture capital (Series C)
$20,000,000
Canaan Partners, Roche Venture Fund, Third Rock Ventures, +1
Venture capital (Series B)
$11,000,000
Canaan Partners, Third Rock Ventures
Employees

Team size

10+
Locations
Unknown
Help us complete this profile

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CytomX Therapeutics makes some noise.